Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction
Status:
Recruiting
Trial end date:
2024-07-31
Target enrollment:
Participant gender:
Summary
The investigators will conducted a randomized double-blind placebo-controlled study to
investigate the treatment outcomes of add-on low dose dextromethorphan (DM), memantine (MM),
or dextromethorphan and memantine combination (DM+MM) in amphetamine-type stimulants use
disorder patients.